- BBBYQ Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
CORRESP Filing
20230930-DK-Butterfly-1 (BBBYQ) CORRESPCorrespondence with SEC
Filed: 5 Apr 23, 12:00am
Attention: | Brian Fetterolf | |
Mara Ransom |
Re: | Bed Bath & Beyond Inc. | ||
Amendment No. 1 to Preliminary Proxy Statement on Schedule 14A | |||
Filed March 31, 2023 | |||
File No. 000-20214 |
1. | Staff’s comment: Revise to discuss the risks you acknowledge in the prospectus dated March 30, 2023, including the issuer's need for liquidity, dilution with the issuance of additional shares of Common Stock, volatility in trading and market prices of the Common Stock, to name just a few risks as examples that should be discussed. |
Securities and Exchange Commission April 5, 2023 Page 2 |
2. | Staff’s comment: We note your disclosure that "[o]ther factors, such as our financial results, market conditions and the market perception of our business, may adversely affect the stock price . . . ." Revise to discuss how issuances pursuant to the Sales Agreement and Purchase Agreement may adversely affect the stock price. In connection therewith, here or as a new risk, discuss how the market price of your Common Stock may impact the proceeds raised pursuant to such agreements, and how a declining price may thereby increase the likelihood of an "Equity Termination Event" under the Credit Agreement and thereby trigger an "Event of Default" that could lead to bankruptcy. |
Sincerely, | ||
/s/ Sue Gove | ||
Sue Gove | ||
President & Chief Executive Officer | ||
Bed Bath & Beyond Inc. |